Micro Bioreactors Market Scope
The rise in biopharmaceutical funding for the manufacturing and development of drugs will help to fuel the micro bioreactor market around the world in the forecasted period. Micro Bioreactors are one of the most important apparatuses for modern biotechnology research and many laboratories. Microbioreactor is a step toward high-throughput bioprocess development, wherein fabrication, fabrication, and characterization, and designing of polymer-based micro bioreactors are integrated with automatic sensors and actuators. There is a various application of micro bioreactors including culturing microbial cells for batch, continuous and fed-batch operations. Furthermore, the expansion of novel technology by several life sciences establishments is anticipated to drive the global micro bioreactors market.
Attributes | Details |
---|
Study Period | 2018-2030 |
Base Year | 2023 |
Unit | Value (USD Million) |
Key Companies Profiled | Sartorius Stedim Biotech (Germany), Pall Corporation (United States), M2p-labs (Germany), Eppendorf (Germany), Merck Millipore (United States), Applikon Biotechnology (Netherlands), Chemtrix (Netherlands), CerCell (Denmark), RUAG Space Nyon (Switzerland) and PreSens Precision Sensing (Germany) |
CAGR | 5.8% |
Research Analyst at AMA estimates that European Players will contribute to the maximum growth of Global Micro Bioreactors market throughout the predicted period.
Sartorius Stedim Biotech (Germany), Pall Corporation (United States), M2p-labs (Germany), Eppendorf (Germany), Merck Millipore (United States), Applikon Biotechnology (Netherlands), Chemtrix (Netherlands), CerCell (Denmark), RUAG Space Nyon (Switzerland) and PreSens Precision Sensing (Germany) are some of the key players that are part of study coverage. Additionally, the Players which are also part of the research are Mani Dharma Biotech Pvt.Ltd (India) and Applikon Biotechnology (Netherlands).
About Approach
The research aims to propose a patent-based approach in searching for potential technology partners as a supporting tool for enabling open innovation. The study also proposes a systematic searching process of technology partners as a preliminary step to select the emerging and key players that are involved in implementing market estimations. While patent analysis is employed to overcome the aforementioned data- and process-related limitations, as expenses occurred in that technology allows us to estimate the market size by evolving segments as target market from the total available market.
Segmentation Overview
The study have segmented the market of Global Micro Bioreactors market by Type , by Application (Sewage Treatment, Biochemical Engineering, Food Industry and Others) and Region with country level break-up.
On the basis of geography, the market of Micro Bioreactors has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
region held largest market share in the year 2023.
Market Leaders and their expansionary development strategies
In May 2019, Sartorius Stedim Biotech (SSB), a leading international partner of the biopharmaceutical industry has launched its new generation of ambr® 15 cell culture automated microbioreactor system. It offers increased flexibility and expanded capability for clone selection, media, and feed optimization and early process development work.
In April 2018, Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry has launched of a new mini bioreactor vessel for its ambr® 250 high throughputs (ht) system. This new vessel, which is designed for optimal growth of adherent cells on microcarriers will enable rapid, scalable cell culture process development of vaccines.
Influencing Trend:
Increase in the Number of Research Activities and High Adoption Due To Development of Biosimilar As Well As Orphan Drugs
Market Growth Drivers:
Increase in the Number of Research Activities and High Adoption Due To Development of Biosimilar As Well As Orphan Drugs
Challenges:
Strict Government Regulations
Restraints:
High Cost of Equipment and Dearth of Skilled Workers to Run Bioreactors
Opportunities:
Huge Demand Due To New Technological Advancement, Growing Demand Due To Automation and the Availability of Online Cultivation Data and Upsurge in Approvals of Cell-Based Vaccines
Key Target Audience
Healthcare Industry, Technology Investors, Integrated Device Manufacturers (IDMs), Research/Consultancy Firms, Government Agencies, Professional Service Providers and Others